Ormeloxifene treatment inhibits growth of cisplatin-resistant ovarian cancer cells

被引：0
|
作者：
Nordquist, Jordan [1 ,2 ]
Maher, Diane M. [1 ]
Ebeling, Mara [1 ]
Jaggi, Meena [1 ,3 ,4 ]
Chauhan, Subhash C. [1 ,3 ,4 ]
机构：
[1] Sanford Res USD, Canc Biol Res Ctr, Sioux Falls, SD USA
[2] Univ S Dakota, Sanford Sch Med, Sioux Falls, SD USA
[3] Univ S Dakota, Sanford Sch Med, Dept OB GYN, Sioux Falls, SD USA
[4] Univ S Dakota, Sanford Sch Med, Basic Biomed Sci Div, Sioux Falls, SD USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-4521
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4521
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Low-dose LBH589 increases the sensitivity of cisplatin to cisplatin-resistant ovarian cancer cells
    Ma, Yen-Ying
    Lin, Hao
    Moh, Jau-Sung
    Chen, Kuang-Den
    Wang, I-Wen
    Ou, Yu-Che
    You, Ying-Shu
    Lung, Chia-Chi
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2011, 50 (02): : 165 - 171
  • [42] Cisplatin-induced, coordinated transcriptional reprogramming of neurotrypsin and other proteases in cisplatin-resistant ovarian cancer cells
    Garcia-Bassets, Ivan
    Almenar-Queralt, Angels
    FASEB JOURNAL, 2012, 26
  • [43] Poly(amido)amine (PAMAM) dendrimer-cisplatin complexes for chemotherapy of cisplatin-resistant ovarian cancer cells
    Yellepeddi, Venkata Kashyap
    Vangara, Kiran Kumar
    Palakurthi, Srinath
    JOURNAL OF NANOPARTICLE RESEARCH, 2013, 15 (09)
  • [44] Oxaliplatin for the treatment of cisplatin-resistant cancer: A systematic review
    Stordal, Britta
    Pavlakis, Nick
    Davey, Ross
    CANCER TREATMENT REVIEWS, 2007, 33 (04) : 347 - 357
  • [45] Proteasome Inhibitor YSY01A Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant Human Ovarian Cancer Cells
    Huang, Wei
    Zhou, Quan
    Yuan, Xia
    Ge, Ze-mei
    Ran, Fu-xiang
    Yang, Hua-yu
    Qiang, Guang-liang
    Li, Run-tao
    Cui, Jing-rong
    JOURNAL OF CANCER, 2016, 7 (09): : 1133 - 1141
  • [46] Sanguinarine enhances cisplatin sensitivity via glutathione depletion in cisplatin-resistant ovarian cancer (A2780) cells
    Sarkhosh-Inanlou, Roya
    Molaparast, Morteza
    Mohammadzadeh, Adel
    Shafiei-Irannejad, Vahid
    CHEMICAL BIOLOGY & DRUG DESIGN, 2020, 95 (02) : 215 - 223
  • [47] ALTERED CISPLATIN METABOLISM IN CISPLATIN-RESISTANT 2008 HUMAN OVARIAN-CARCINOMA CELLS
    ANDREWS, PA
    KIM, RW
    MURPHY, MP
    HOWELL, SB
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 270 - 270
  • [48] Overcoming treatment resistance in cisplatin-resistant ovarian carcinoma cells by tissue-specific miRNAs
    Kleemann, Michael
    Bereuther, Jeremias
    Fischer, Simon
    Marquart, Kim
    Hanle, Simon
    Unger, Kristian
    Jendrossek, Verena
    Riedel, Christian U.
    Handrick, Rene
    Otte, Kerstin
    CANCER RESEARCH, 2017, 77
  • [49] Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells
    Marzano, Christine
    Gandin, Valentina
    Folda, Alessandra
    Scutari, Guido
    Bindoli, Alberto
    Rigobello, Maria Pia
    FREE RADICAL BIOLOGY AND MEDICINE, 2007, 42 (06) : 872 - 881
  • [50] Cantrixil targets ovarian cancer stem cells and prevents recurrence in a cisplatin-resistant animal model
    Mor, Gil G.
    Lima, Eydis
    Sumi, Natalia
    Pitruzzello, Mary
    Yang-Hartwich, Yang
    Brown, David
    Heaton, Andrew
    Alvero, Ayesha B.
    CANCER RESEARCH, 2015, 75
12345